For decades, the message about HDL cholesterol was simple: it's the "good cholesterol," so a higher number is better. A large new genetic study suggests that message, while not wrong, is incomplete. HDL levels still matter, but the size and quality of HDL particles appear to carry separate, independent information about heart risk, information a standard cholesterol test doesn't capture at all.
A Massive Look Inside Our Blood
An international research team analyzed blood samples from more than 450,000 UK Biobank participants. Instead of relying on a standard cholesterol test, they used a technique called NMR spectroscopy, which can measure 249 different blood metabolites at once, including detailed breakdowns of HDL and LDL by particle size, not just the total amount present. They then mapped how genetic variation shapes these traits, producing one of the most detailed genetic maps of human metabolism published to date, in the journal Nature Genetics.
In simple terms, NMR spectroscopy can tell the difference between someone whose HDL particles tend to be small and dense versus someone whose HDL particles tend to be large and "fluffy," a distinction that a routine lipid panel simply cannot make.
Quantity and Quality, Together
A standard cholesterol test gives you one HDL number, and that number remains a useful, well-established marker on its own. But this study found that HDL particle size, largely determined by genetics, is linked to cardiovascular outcomes independently of that single number.
The clearest example involved coronary artery disease. People with a genetic tendency toward larger HDL particles had a 35 percent lower risk of coronary artery disease, even after the researchers statistically accounted for overall HDL levels. In other words, two people with an identical HDL number could have meaningfully different heart disease risk depending on the size of the particles carrying that cholesterol.
A Clue About Why This Happens
The researchers didn't just find a statistical pattern, they also traced part of it back to a specific gene involved in blood vessel health. That gene is already well known in a completely different area of medicine: it plays a role in how blood vessels grow, and it's been studied for years as a target in cancer treatment.
This same gene showed up strongly linked to both HDL particle size and coronary artery disease risk in the study. The researchers believe it may help control how efficiently HDL particles carry cholesterol out of artery walls and back to the liver for disposal. In simple terms, this gives scientists an actual biological explanation for the pattern they observed, rather than just a correlation with no clear cause.
This kind of finding is valuable precisely because it points toward a specific, testable mechanism inside the body, rather than simply reporting a statistical association without any explanation for why it might exist.
Why This Matters
This research may help explain a long-standing puzzle in cardiology. Several drugs designed simply to raise HDL levels have failed in large clinical trials to meaningfully reduce heart attacks or deaths, disappointing results that have puzzled researchers for years. This study suggests one possible explanation: raising the quantity of HDL without improving its quality or function may not deliver the cardiovascular benefit doctors once expected.
The researchers argue that future prevention strategies may need to consider both dimensions together, not just how much HDL a person has, but how well it functions and what size the particles tend to be. Together, these factors may offer a more complete picture of cardiovascular risk than HDL level alone.
What the Study Found: Quick Summary
| Finding | Detail |
|---|---|
| Study size | ~450,000 UK Biobank participants |
| Method | NMR spectroscopy measuring 249 blood metabolites |
| Key result | Genetically larger HDL particles linked to 35% lower coronary artery disease risk |
| Independent of HDL level? | Yes, effect held after accounting for overall HDL cholesterol |
| Biological clue found | A gene involved in blood vessel health, also studied in cancer research |
| Clinical test available today? | No, HDL particle size is not yet part of routine testing |
Frequently Asked Questions
Q: Can I get my HDL particle size tested right now?
Not as part of routine clinical care. NMR-based particle size testing exists in research settings and some specialized labs, but it isn't yet a standard part of a typical cholesterol screening, and no treatment currently targets HDL particle size specifically.
Q: Does this mean my HDL number doesn't matter anymore?
No. HDL level remains a meaningful, well-established marker, and this study doesn't change that. It simply suggests particle size adds independent information on top of the number, rather than replacing it.
Q: Did this study find the same strong link for stroke and heart attack specifically, or just coronary artery disease?
The clearest, statistically robust finding was specifically for coronary artery disease. The researchers examined 25 cardiovascular conditions broadly, but coronary artery disease stood out as one of the few conditions with strong, independent evidence linking it to HDL particle characteristics beyond standard LDL-related pathways.
Key Takeaway
HDL levels are still worth paying attention to, but this large genetic study suggests they're only part of the picture. Particle size and quality appear to carry separate information about coronary artery disease risk, information not visible on a standard cholesterol test. No treatment specifically targets HDL quality yet, so the most useful step today is discussing your overall cardiovascular risk profile with your doctor, treating your HDL number as one piece of that picture rather than the whole story.
References
- Zoodsma M, Beuchel C, Yasmeen S, et al. A Genetic Map of Human Metabolism Across the Allele Frequency Spectrum. Nature Genetics. 2025;57:2445-2455. doi.org/10.1038/s41588-025-02355-3
Comments
Post a Comment